Health ❯ Diseases ❯ Neurological Disorders

Huntington's Disease

Genetic Factors Glial Progenitor Cells Glial Cells Protein Function Disease Progression Monitoring

uniQure Gene Therapy Reports 75% Slowing of Huntington’s Progression at 36 Months

Early results from a small Phase 1/2 study using external natural‑history controls will guide an FDA filing planned for early 2026.

Healthy Glial Cell Transplants Slow Huntington’s Progression in Adult Mice

Study Identifies Opposing Roles of Two Proteins in Huntington’s Disease

Northern Scotland Identified as Global Hotspot for Huntington’s Disease in Landmark Study

Breakthrough Study Uncovers Key Trigger in Huntington’s Disease Progression